When chemotherapy targets cancer cells, it often triggers a stromal reaction, leading to TNF‐α production by stromal and endothelial cells.[27] By blocking IL‐8 in the TME, we can disrupt this autocrine positive feedback loop between IL‐8 and tumor cells, thereby enhancing drug sensitivity. The gene discussed is CXCL8; the disease is neoplasm.